Johnson & Johnson Eyes Major Leap in Biotech: Talks Underway to Acquire Protagonist Therapeutics in Billion-Dollar Move
In a bold bid to expand its cutting-edge drug pipeline, Johnson & Johnson is reportedly in advanced talks to acquire
Read More
Factual Version of a Story
global biotech investments